Key takeaway for GLP-1 therapy and muscle: the body rebalances tissues as weight and energy needs decline
The oral formulation appears to be bringing new patients into treatment rather than simply shifting share among existing users
1 Emerging and investigational directions being discussed in the literature include: Personalized risk stratification , using dose, sex, rate of weight loss, and baseline hair status to predict which patients need proactive hair-protective counseling before starting a GLP-1
Market Background 1.2 Executive Summary 1.3 Research Methodology 2
Used to screen for diabetes or prediabetes Lipid panel : Checks cholesterol levels, which are key for heart health Comprehensive metabolic panel (CMP): Evaluates kidney and liver function to ensure medication safety High-sensitivity C-reactive protein (CRP): Detects inflammation, a marker tied to chronic disease risk [1] Fasting insulin: Assesses insulin resistance, often linked to weight gain and metabolic issues [2] Thyroid-stimulating hormone (TSH): Screens for thyroid imbalances that can affect weight and energy These labs help your clinician choose the safest and most effective GLP-1 medication for you
BMC Cardiovasc Disord, 2014, 14, 88